The association between hepatitis C infection and survival after orthotopic liver transplantation.

By L. Forman, James D. Lewis, Jesse Berlin, Harold I. Feldman, M. Lucey. Gastroenterology, 2002

1,158 citations recorded by the source corpus.

Subfields: Hepatology, Surgery, Transplantation

View Paper: https://www.semanticscholar.org/paper/92bf02dd72b6cdad57b2ebb564f811c987f567f3

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Hepatology

1. Christoph Sarrazin
2. A. Aghemo
3. Andrew K. Burroughs
4. G. Dusheiko
5. M. Puoti
6. X. Forns
7. J. Pawlotsky

Citations in the corpus

• EASL Clinical Practice Guidelines: management of hepatitis C virus infection. (2011, background): “The course of HCV-related liver disease is accelerated in liver transplant recipients and approximately one third of them develop cirrhosis within 5 years following transplantation [130,131].”
• EASL Recommendations on Treatment of Hepatitis C 2018. (2018, neutral): “within 5 years following transplantation [68, 69].”
• Ledipasvir and Sofosbuvir Plus Ribavirin for Treatment of HCV Infection in Patients With Advanced Liver Disease. (2015, neutral): “Sepsis 0 2 (7) 0 0 0 0 0 0 0 0 0 0 0 0 Gastric hemorrhage 0 1 (3) 0 0 0 0 0 0 1 (4) 0 0 0 0 0 Acute renal failure 0 0 0 1 (4) 0 0 0 0 0 1 (4) 0 0 0 0 ALT level increased 0 0 0 0 0 1 (2) 0 0 0 0 0 0 0 0 AST level increased 0 0 0 0 0 1 (2) 0 0 0 0 0 0 0 0 Aortic dissection 0 0 0 0 0 0 0 0 0 1 (4) 0 0 ”
• EASL Recommendations on Treatment of Hepatitis C 2016. (2017, neutral): “within 5 years following transplantation [68, 69].”
• EASL Clinical Practice Guidelines: Liver transplantation. (2016, background): “Progression of hepatitis C is accelerated after LT and HCV-infected recipients have a reduced graft and patient survival when compared to HCV negative recipients [381].”
• EASL Recommendations on Treatment of Hepatitis C 2015. (2015, background): “The course of HCV-related liver disease is accelerated in liver transplant recipients and approximately one-third of them develop cirrhosis within 5 years following transplantation [96,97].”
• Computer‐assisted image analysis of liver collagen: Relationship to Ishak scoring and hepatic venous pressure gradient (2009, background): “23,24 In this setting, survival is less than for other liver transplantation (LT) indications such as alcohol-related cirrhosis.”